From binary to gradient: EUS-RFA redefines primary aldosteronism therapy

Mullen N, Curneen J, Donlon PT, Prakash P, Bancos I, Gurnell M, et al. Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks. Endocr Rev. 2024;45:125–70.

PubMed  Google Scholar 

Heinze B, Fuss CT, Mulatero P, Beuschlein F, Reincke M, Mustafa M, et al. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of Aldosterone-producing adenoma. Hypertension. 2018;71:317–25.

CAS  PubMed  Google Scholar 

Zennaro MC, Boulkroun S, Fernandes-Rosa FL. Pathogenesis and treatment of primary aldosteronism. Nat Rev Endocrinol. 2020;16:578–89.

CAS  PubMed  Google Scholar 

Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder RE, et al. Safety and efficacy of renal denervation in patients taking antihypertensive medications. J Am Coll Cardiol. 2023;82:1809–23.

CAS  PubMed  Google Scholar 

Zhao Z, Liu X, Zhang H, Li Q, He H, Yan Z, et al. Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial. Circulation. 2021;144:580–2.

PubMed  Google Scholar 

Park BK. Percutaneous adrenal radiofrequency ablation: a short review for endocrinologists. Endocrinol Metab. 2020;35:750–5.

CAS  Google Scholar 

Argentesi G, Wu X, Ney A, Goodchild E, Laycock K, Lee YN, et al. Endoscopic, ultrasound-guided, radiofrequency ablation of aldosterone-producing adenomas (FABULAS): a UK, multicentre, prospective, proof-of-concept trial. Lancet. 2025;405:637–47.

CAS  PubMed  Google Scholar 

Williams TA, Lenders J, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689–99.

PubMed  PubMed Central  Google Scholar 

Yang J, Burrello J, Goi J, Reincke M, Adolf C, Asbach E, et al. Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort. Lancet Diabetes Endocrinol. 2025;13:119–33.

PubMed  Google Scholar 

Chen SY, Chen JY, Huang WC, Puar T, Chin KP, Chueh JS, et al. Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis. Eur J Endocrinol. 2022;187:S47–58.

CAS  PubMed  Google Scholar 

Comments (0)

No login
gif